Antimicrobial susceptibility of Neisseria gonorrhoeae in Greece: Data for the years 1994-2004

Journal of Antimicrobial Chemotherapy

Volumn 57, Issue 4, 2006, Pages 775-779

  Stathi, Maria ^a   Flemetakis, Alexandros ^b   Miriagou, Vivi ^a   Avgerinou, Helen ^b   Kyriakis, Kyriakos P ^a   Maniatis, Antonios N ^c   Tzelepi, Eva ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b ANDREAS SYGROS HOSPITAL   (Greece)

^c UNIVERSITY OF THESSALY   (Greece)

Author keywords

Antibiotic resistance; Fluoroquinolones; Gonorrhoea; N. gonorrhoeae

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; ERYTHROMYCIN; NALIDIXIC ACID; NORFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPECTINOMYCIN; TETRACYCLINE;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHROMOSOME; CONTROLLED STUDY; DATA ANALYSIS; DRUG CLASSIFICATION; FEMALE; GONORRHEA; GREECE; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; PLASMID; QUANTITATIVE ANALYSIS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; GONORRHEA; GREECE; HUMANS; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; POPULATION SURVEILLANCE;

EID: 33645113626     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl040     Document Type: Article

References (12)

1. Tapsal J. Current concepts in the management of gonorrhoea. Expert Opin Pharmacother 2002; 3: 147-57.
2. Ison CA, Martin IMC and the London Gonococcal Working Group. Susceptibility of gonococci isolated in London to therapeutic antibiotics: Establishment of a London surveillance system. Sex Transm Infect 1999; 75: 107-11.
3. Lowndes CM, Fenton KA and the ESSTI (European Surveillance of STIs) Network. Surveillance systems for STIs in the European Union: Facing a changing epidemiology. Sex Transm Infect 2004; 80: 264-71.
4. Tzelepi E, Avgerinou H, Kyriakis KP et al. Antimicrobial susceptibility and types of Neisseria gonorrhoeae in Greece - data for the period 1990 to 1993. Sex Transm Dis 1997; 24: 378-85.
5. Kyriakis KP, Tzelepi E, Flemetakis A et al. Epidemiologic aspects of male gonococcal infection in Greece. Sex Transm Dis 1999; 29: 43-8.
6. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement M100-S12. NCCLS, Wayne, PA, USA, 2002.
7. Gascoyne-Binzi DM, Hawkey PM, Heritage J. The distribution of the Tet M determinant in tetracycline-resistant Neisseria gonorrhoeae. J Antimicrob Chemother 1994; 33: 1011-6.
8. Deguchi T, Yasuda M, Nakano M et al. Quinolone-resistant Neisseria gonorrhoeae: Correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles. Antimicrob Agents Chemother 1996; 40: 1020-3.
9. Mavroidi A, Tzouvelekis LS, Kyriakis KP et al. Multidrug-resistant strains of Neisseria gonorrhoeae in Greece. Antimicrob Agents Chemother 2001; 45: 2651-4.
10. Greco V, Ng LK, Catana R et al. Molecular epidemiology of Neisseria gonorrhoeae isolates with plasmid-mediated tetracycline resistance in Canada: Temporal and geographical trends (1986-1997). Microb Drug Resist 2003; 9: 353-60.
11. Mavroidi A, Tzouvelekis LS, Tassios PT et al. Characterization of Neisseria gonorrhoeae strains with decreased susceptibility to fluoroquinolones isolated in Greece during 1996-1999. J Clin Microbiol 2000; 38: 3489-91.
12. Dan M. The use of fluoroquinolones in gonorrhoea: The increasing problem of resistance. Expert Opin Pharmacother 2004; 5: 829-54.